Drug
cabotegravir
Marketed as APRETUDE.
Generic name
cabotegravir
Brand names
APRETUDE
First FDA approval
2021-12-20
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA215499 | APRETUDE | 2021-12-20 | VIIV HLTHCARE |
Manufacturers
VIIV HLTHCARE
Frequently asked questions
When was cabotegravir FDA approved?
Earliest FDA approval on record: 2021-12-20.
What brand names are sold as cabotegravir?
APRETUDE.
Sources
Appeal a cabotegravir denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com